Completed processing the data of two large randomized, placebo-controlled clinical trials of the drug “Anaferon children”.
International multicentre double-blind placebo-controlled randomized clinical trial in parallel groups efficacy in the treatment of influenza and acute respiratory viral infections in children was conducted in 26 health facilities in the territory of Russia, Ukraine and Belarus with the participation of 610 children with ARVI and influenza are mild and moderate severity at the age from 3 to 12 years inclusive.
Another international multicenter, double-blind, placebo-controlled randomized clinical trial in parallel groups efficacy in the prevention of influenza and other acute respiratory viral infections in children in the period of seasonal rise of morbidity was conducted on the basis of 22 medical institutions of Russia and the Republic of Uzbekistan. The study involved 710 children aged from 1 month to 6 years, inclusive.
The results of the research will be published in the near future.